Due to cannabis’ federal Schedule I status, there are several limitations to who can provide cannabis and if insurance is able to step in and assist with the cost of seeing a provider and covering the cost of the cannabis. In states that allow medical marijuana programs, healthcare providers can’t prescribe medical marijuana, but healthcare providers can recommend it or make a referral to a state dispensary, or in some states, they are called pharmacies. A dispensary or pharmacy is a designated store where marijuana is sold outside the realm of traditional pharmaceuticals.
Even though cannabis is legal in 75% of the United States, most private and public insurance companies will not pay for medical marijuana recommendation use or marijuana products. Again, this all comes back to the fact that cannabis is federally illegal. Private insurance companies that operate on a national level must comply with federally-mandated coverage requirements. This means that most don’t want to risk entering the illegal muddy waters of medical cannabis, even if cannabis is legal in the state.
Medicaid, the federally operated health insurance organization, focuses on helping low-income individuals access affordable medication and healthcare but cannot assist patients in gaining access to medical cannabis because it is federally funded. A recent survey by MedicarePlans.com found that 2 in 3 Medicare beneficiaries said that Medicare should cover medical marijuana. This survey also found that 6 in 10 of those who support coverage said the reason is they believe cannabis can be effective when other treatments fall short.
There is one loophole to insurance covering the cost of medical marijuana. There are three FDA-approved prescription medications that contain cannabinoids. Healthcare providers can prescribe them, and Medicare may cover the cost. The FDA-approved cannabinoid-based medications are:
There is hope on the horizon. Medicaid is a joint federal and state program that gives health coverage to some people with limited income and resources. Because Maedicaid has state involvement, there is some wiggle room on medical cannabis. The state of New York offers Medicaid services reimbursement through Medicaid for patient evaluation and certification, though not for products.
On the flip side, New Hampshire and New Mexico allow for the reimbursement of medical marijuana purchases on a state level. More recently, court cases in Pennsylvania and New Jersey have successfully argued for medical marijuana reimbursement in the case of workers’ compensation. Overall, on a national level, Medicaid is in the same boat as Medicare and will likely not assist with medical marijuana for several years or until the laws and regulations change.
Recently, a Pennsylvania appeals court ruled that the state’s medical marijuana law does not prohibit insurers from reimbursing injured workers for medical marijuana in cases where the drug is used to treat accepted work injuries.
In a worker’s compensation case filed by Paul Sheetz while working for Firestone Tire and Rubber, the Pennsylvania Commonwealth Court ruled that the state’s Workers’ Compensation Appeal Board made an error when it upheld a decision by Firestone Tire & Rubber to deny reimbursement for the cost of Paul Sheetz’s medical marijuana. Sheetz, who is now deceased, had been using medical marijuana to treat chronic pain from a 1977 work injury. He had used medical marijuana to taper off the decades of prescribed opioid use.
Ms. Kaufman, a Pennsylvania-based attorney who represented Sheetz, said the case means insurers must reimburse marijuana costs in cases where the treatment is deemed “reasonable and necessary” and that reimbursement would likely only come in serious or old injury cases where medical marijuana is the “primary treatment modality.” Firestone’s stance was that providing medical marijuana would violate federal law if forced to reimburse for medical marijuana. The court ruled reimbursement is not a federal crime because insurers are not prescribing the drug themselves.
To help offset the cost that insurance will not cover, several states and cities have programs that offer assistance with free or discounted medical marijuana patient ID cards, registration, and the cost of products. Until insurance companies are able to assist patients with costs, unfortunately, many will turn to opioids and benzodiazepines to treat pain and other issues. Insurance covering the cost of medical cannabis would be a step in the right direction of harm reduction against addictive pharmaceuticals covered by insurance.
Is this coverage available in Oklahoma?
The ( govt. ) has never gave a shit
about humans consuming opiates
& becoming hooked. They say they care because the American believe
it. Just another form of population
reductions. Thanks for your time.
“Do you prefer an indica or a sativa?” is typically the first question asked at a dispensary. Indica vs. sativa refers to the two main categories of cannabis strains. Both indicas and sativas differ in appearance and effects. Indicas are generally known for a sedating effect, while sativa strains are known for a cerebral high….
Cancer can be a harrowing journey, not only due to the disease itself but also because of the relentless pain that often accompanies it. Conventional pain management strategies, such as opioids and other medications, can sometimes fall short in providing lasting relief or cause undesirable side effects. But what if a safe and effective complementary…
A bill was passed to legalize the possession and sharing of certain psychedelics for Californians aged 21 and above. The bill underwent an accelerated process that allowed it to bypass further committee consideration; thus, it was moved directly to the Senate floor. The legislation was sponsored by Sen. Scott Wiener (D), and he explained that…
The U.S. Secret Service (USSS) recently loosened its applicant drug use policy to be more accommodating to past cannabis consumers. Candidates of all ages can now apply to join the agency if they have abstained from marijuana for one year before applying. Before this policy, cannabis use within the past three years led to automatic disqualification. …
Ohio introduced a legalization bill, cannabis and psilocybin could be the future of cancer care, and a ketamine company is looking to take the lead in the space. Let’s dive into this week’s canna-news. Ohio Eyes Legalization With HB 168 Ohio is inching closer to making cannabis legalization a reality. The bipartisan-backed House Bill 168—the…
On April 21, 2023, Delaware became the 22nd state to legalize marijuana—despite the governor’s opposition. Gov. John Carney (D) passed two bills…
Currently, numerous scientific studies support using cannabis for pain and inflammation. For example, a noteworthy study published by the Journal of the…
June is Alzheimer’s and Brain Awareness Month, and we’re diving into the role of cannabis in brain health. In today’s fast-paced world,…